Urogen Pharma Ltd (URGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -153,494 | -126,874 | -102,244 | -109,783 | -110,820 |
| Depreciation Amortization | -1,568 | -2,562 | -232 | 426 | 1,307 |
| Accounts receivable | -12,780 | -4,859 | -2,739 | -987 | -4,671 |
| Other Working Capital | -27,914 | 4,933 | 3,336 | -6,306 | -14,282 |
| Other Operating Activity | 33,312 | 32,596 | 25,503 | 29,091 | 43,574 |
| Operating Cash Flow | $-162,444 | $-96,766 | $-76,376 | $-87,559 | $-84,892 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 61,847 | -20,318 | -759 | 1,314 | 4,821 |
| PPE Investments | -289 | -295 | -194 | -254 | -752 |
| Investing Cash Flow | $61,558 | $-20,613 | $-953 | $1,060 | $4,069 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | 24,488 | N/A | 95,783 | N/A |
| Common Stock Issued | 41,773 | 170,131 | 116,931 | 1,511 | 61 |
| Other Financing Activity | -1,855 | 0 | 0 | -160 | 72,258 |
| Financing Cash Flow | $39,918 | $194,619 | $116,931 | $97,134 | $72,319 |
| Beginning Cash Position | 173,063 | 95,823 | 56,221 | 45,586 | 54,090 |
| End Cash Position | 112,095 | 173,063 | 95,823 | 56,221 | 45,586 |
| Net Cash Flow | $-60,968 | $77,240 | $39,602 | $10,635 | $-8,504 |
| Free Cash Flow | |||||
| Operating Cash Flow | -162,444 | -96,766 | -76,376 | -87,559 | -84,892 |
| Capital Expenditure | -289 | -295 | -194 | -254 | -752 |
| Free Cash Flow | -162,733 | -97,061 | -76,570 | -87,813 | -85,644 |